IMRX Scorecard | Immuneering Corporation

40 QUARTERS × 3 ROAST BATTLES

5/120 0.2 / 5 stars All 120 Win/Lose results shown below

IMRX Roast Me summary

Immuneering Corp (IMRX). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.

Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 25 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q20/3	LoseIMRX / S&P -5.31% / 15.20%	LoseIMRX / S&P IMRX unavailable / 15.00%	LoseIMRX / S&P IMRX unavailable / 50.40%
2026-Q10/3	LoseIMRX / S&P -19.91% / -4.33%	LoseIMRX / S&P IMRX unavailable / 11.30%	LoseIMRX / S&P IMRX unavailable / 27.70%
2025-Q40/3	LoseIMRX / S&P -6.00% / 2.65%	LoseIMRX / S&P IMRX unavailable / 9.00%	LoseIMRX / S&P IMRX unavailable / 13.40%
2025-Q31/3	WinIMRX / S&P 107.72% / 8.12%	LoseIMRX / S&P IMRX unavailable / 4.61%	LoseIMRX / S&P IMRX unavailable / 13.45%
2025-Q21/3	WinIMRX / S&P 121.71% / 10.94%	LoseIMRX / S&P IMRX unavailable / 4.83%	LoseIMRX / S&P IMRX unavailable / 10.63%
2025-Q10/3	LoseIMRX / S&P -30.91% / -4.27%	LoseIMRX / S&P IMRX unavailable / 4.98%	LoseIMRX / S&P IMRX unavailable / 10.57%
2024-Q40/3	LoseIMRX / S&P -11.65% / 2.41%	LoseIMRX / S&P IMRX unavailable / 5.25%	LoseIMRX / S&P IMRX unavailable / 6.15%
2024-Q31/3	WinIMRX / S&P 94.53% / 5.89%	LoseIMRX / S&P IMRX unavailable / 5.89%	LoseIMRX / S&P IMRX unavailable / 6.11%
2024-Q20/3	LoseIMRX / S&P -55.71% / 4.28%	LoseIMRX / S&P IMRX unavailable / 5.38%	LoseIMRX / S&P IMRX unavailable / 5.12%
2024-Q10/3	LoseIMRX / S&P -60.68% / 10.56%	LoseIMRX / S&P IMRX unavailable / 5.71%	LoseIMRX / S&P IMRX unavailable / 5.59%
2023-Q40/3	LoseIMRX / S&P -4.30% / 11.69%	LoseIMRX / S&P -100.00% / 6.81%	LoseIMRX / S&P IMRX unavailable / 7.78%
2023-Q30/3	LoseIMRX / S&P -24.26% / -3.27%	LoseIMRX / S&P -99.91% / 7.52%	LoseIMRX / S&P IMRX unavailable / -5.03%
2023-Q20/3	LoseIMRX / S&P 4.43% / 8.74%	LoseIMRX / S&P -95.91% / 9.50%	LoseIMRX / S&P IMRX unavailable / -8.57%
2023-Q11/3	WinIMRX / S&P 100.21% / 7.50%	LoseIMRX / S&P -91.21% / 10.77%	LoseIMRX / S&P IMRX unavailable / -15.69%
2022-Q40/3	LoseIMRX / S&P -66.13% / 7.56%	LoseIMRX / S&P -84.76% / 11.88%	LoseIMRX / S&P IMRX unavailable / -17.99%
2022-Q31/3	WinIMRX / S&P 164.70% / -4.88%	LoseIMRX / S&P -80.20% / 13.47%	LoseIMRX / S&P IMRX unavailable / -1.41%
2022-Q20/3	LoseIMRX / S&P -16.38% / -16.10%	LoseIMRX / S&P -65.53% / 13.71%	LoseIMRX / S&P IMRX unavailable / 11.04%
2022-Q10/3	LoseIMRX / S&P -59.99% / -4.60%	LoseIMRX / S&P -41.19% / 15.97%	LoseIMRX / S&P IMRX unavailable / 42.23%
2021-Q40/3	LoseIMRX / S&P -39.10% / 11.03%	LoseIMRX / S&P -10.02% / 15.00%	LoseIMRX / S&P IMRX unavailable / 96.40%
2021-Q30/3	LoseIMRX / S&P IMRX unavailable / 0.58%	LoseIMRX / S&P IMRX unavailable / 10.77%	LoseIMRX / S&P IMRX unavailable / 69.42%
2021-Q20/3	LoseIMRX / S&P IMRX unavailable / 8.55%	LoseIMRX / S&P IMRX unavailable / 6.58%	LoseIMRX / S&P IMRX unavailable / 51.81%
2021-Q10/3	LoseIMRX / S&P IMRX unavailable / 6.17%	LoseIMRX / S&P IMRX unavailable / -1.06%	LoseIMRX / S&P IMRX unavailable / 7.39%
2020-Q40/3	LoseIMRX / S&P IMRX unavailable / 12.15%	LoseIMRX / S&P IMRX unavailable / -3.72%	LoseIMRX / S&P IMRX unavailable / -33.42%
2020-Q30/3	LoseIMRX / S&P IMRX unavailable / 8.93%	LoseIMRX / S&P IMRX unavailable / -2.04%	LoseIMRX / S&P IMRX unavailable / -27.10%
2020-Q20/3	LoseIMRX / S&P IMRX unavailable / 20.54%	LoseIMRX / S&P IMRX unavailable / -0.46%	LoseIMRX / S&P IMRX unavailable / -27.11%
2020-Q10/3	LoseIMRX / S&P IMRX unavailable / -19.60%	LoseIMRX / S&P IMRX unavailable / 3.47%	LoseIMRX / S&P IMRX unavailable / -14.75%
2019-Q40/3	LoseIMRX / S&P IMRX unavailable / 9.07%	LoseIMRX / S&P IMRX unavailable / 5.36%	LoseIMRX / S&P IMRX unavailable / 2.99%
2019-Q30/3	LoseIMRX / S&P IMRX unavailable / 1.70%	LoseIMRX / S&P IMRX unavailable / 5.02%	LoseIMRX / S&P IMRX unavailable / 0.21%
2019-Q20/3	LoseIMRX / S&P IMRX unavailable / 4.30%	LoseIMRX / S&P IMRX unavailable / 6.64%	LoseIMRX / S&P IMRX unavailable / 8.65%
2019-Q10/3	LoseIMRX / S&P IMRX unavailable / 13.65%	LoseIMRX / S&P IMRX unavailable / 8.12%	LoseIMRX / S&P IMRX unavailable / 14.29%
2018-Q40/3	LoseIMRX / S&P IMRX unavailable / -13.52%	LoseIMRX / S&P IMRX unavailable / 9.05%	LoseIMRX / S&P IMRX unavailable / 18.23%
2018-Q30/3	LoseIMRX / S&P IMRX unavailable / 7.71%	LoseIMRX / S&P IMRX unavailable / 10.21%	LoseIMRX / S&P IMRX unavailable / 19.06%
2018-Q20/3	LoseIMRX / S&P IMRX unavailable / 3.43%	LoseIMRX / S&P IMRX unavailable / 9.03%	LoseIMRX / S&P IMRX unavailable / 14.46%
2018-Q10/3	LoseIMRX / S&P IMRX unavailable / -0.76%	LoseIMRX / S&P IMRX unavailable / 7.68%	LoseIMRX / S&P IMRX unavailable / 12.46%
2017-Q40/3	LoseIMRX / S&P IMRX unavailable / 6.64%	LoseIMRX / S&P IMRX unavailable / 7.03%	LoseIMRX / S&P IMRX unavailable / 13.82%
2017-Q30/3	LoseIMRX / S&P IMRX unavailable / 4.48%	LoseIMRX / S&P IMRX unavailable / 5.68%	LoseIMRX / S&P IMRX unavailable / 17.57%
2017-Q20/3	LoseIMRX / S&P IMRX unavailable / 3.09%	LoseIMRX / S&P IMRX unavailable / 4.83%	LoseIMRX / S&P IMRX unavailable / 17.74%
2017-Q10/3	LoseIMRX / S&P IMRX unavailable / 6.07%	LoseIMRX / S&P IMRX unavailable / 3.67%	LoseIMRX / S&P IMRX unavailable / 13.32%
2016-Q40/3	LoseIMRX / S&P IMRX unavailable / 3.82%	LoseIMRX / S&P IMRX unavailable / 2.09%	LoseIMRX / S&P IMRX unavailable / 7.05%
2016-Q30/3	LoseIMRX / S&P IMRX unavailable / 3.85%	LoseIMRX / S&P IMRX unavailable / 0.20%	LoseIMRX / S&P IMRX unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-28

Metric	IMRX total return	S&P 500 Total Return Index
Total return	-13.47%	20.78%
Annualized return	-13.47%	20.78%

5Y · 2021-09-01 to 2026-08-28

Metric	IMRX total return	S&P 500 Total Return Index
Total return	-80.90%	83.14%
Annualized return	-28.19%	12.86%

10Y · 2021-07-30 to 2026-08-28

Metric	IMRX total return	S&P 500 Total Return Index
Total return	-71.71%	319.30%
Annualized return	-11.86%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-25.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Quantum Cyber N.V. (QUCY)		$0.113B
BICYCLE THERAPEUTICS PLC (BCYC)		$0.112B	-1.56
GENELUX Corp (GNLX)	United States	$0.110B	-3.83
Equillium, Inc. (EQ)	United States	$0.109B	-11.27
OnKure Therapeutics, Inc. (OKUR)	United States	$0.119B	-3.13
Biomea Fusion, Inc. (BMEA)	United States	$0.107B	-3.30
Polaryx Therapeutics, Inc. (PLYX)	United States	$0.106B
Coya Therapeutics, Inc. (COYA)	United States	$0.121B	-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)	United States	$0.121B	-8.95
Aardvark Therapeutics, Inc. (AARD)	United States	$0.121B	-1.80